Selected article for: "cell cell fusion and host cell entry"
Author: Najafi Fard, Saeid; Petrone, Linda; Petruccioli, Elisa; Alonzi, Tonino; Matusali, Giulia; Colavita, Francesca; Castilletti, Concetta; Capobianchi, Maria Rosaria; Goletti, Delia
Title: In Vitro Models for Studying Entry, Tissue Tropism, and Therapeutic Approaches of Highly Pathogenic Coronaviruses
  • Cord-id: yrwvhq53
  • Document date: 2021_6_21
    • ID: yrwvhq53
    Snippet: Coronaviruses (CoVs) are enveloped nonsegmented positive-sense RNA viruses belonging to the family Coronaviridae that contain the largest genome among RNA viruses. Their genome encodes 4 major structural proteins, and among them, the Spike (S) protein plays a crucial role in determining the viral tropism. It mediates viral attachment to the host cell, fusion to the membranes, and cell entry using cellular proteases as activators. Several in vitro models have been developed to study the CoVs entr
    Document: Coronaviruses (CoVs) are enveloped nonsegmented positive-sense RNA viruses belonging to the family Coronaviridae that contain the largest genome among RNA viruses. Their genome encodes 4 major structural proteins, and among them, the Spike (S) protein plays a crucial role in determining the viral tropism. It mediates viral attachment to the host cell, fusion to the membranes, and cell entry using cellular proteases as activators. Several in vitro models have been developed to study the CoVs entry, pathogenesis, and possible therapeutic approaches. This article is aimed at summarizing the current knowledge about the use of relevant methodologies and cell lines permissive for CoV life cycle studies. The synthesis of this information can be useful for setting up specific experimental procedures. We also discuss different strategies for inhibiting the binding of the S protein to the cell receptors and the fusion process which may offer opportunities for therapeutic intervention.

    Search related documents:
    Co phrase search for related documents
    • absence presence and abundant presence: 1
    • absence presence and accessory protein: 1, 2
    • absence presence and activate leukocyte: 1
    • absence presence and active site: 1, 2, 3, 4, 5, 6, 7, 8
    • absence presence and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • absence presence and liver lymph: 1, 2, 3
    • abundant presence and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4
    • accessory protein and active site: 1, 2
    • accessory protein and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acidic environment and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4
    • acidic environment and liver lymph: 1, 2
    • activation step and acute sars cov respiratory syndrome coronavirus: 1, 2
    • active site and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • activity chemokine and acute sars cov respiratory syndrome coronavirus: 1, 2, 3
    • acute sars cov respiratory syndrome coronavirus and adequate processing: 1